NCT06588426 Clinical Readiness Skin Punch Biopsy Sample Collections
| NCT ID | NCT06588426 |
| Status | Recruiting |
| Phase | — |
| Sponsor | HeartWorks, Inc. |
| Condition | Congenital Heart Disease (CHD) |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2024-09-13 |
| Primary Completion | 2027-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2024-09-13 with a primary completion date of 2027-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a clinical readiness skin punch biopsy sample collection study. This will allow to reduce manufacturing time when patients are identified as eligible to receive product under separate interventional treatment protocol.
Eligibility Criteria
Inclusion Criteria: * Age 18 and older * Congenital heart disease * Likely to qualify for an active clinical trial under IND 28611 in the future Exclusion Criteria: * Previous cardiac transplantation * Unable or unwilling to consent * HIV diagnosis * Hepatitis diagnosis
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06588426 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Congenital Heart Disease (CHD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06588426 currently recruiting?
Yes, NCT06588426 is actively recruiting participants. Contact the research team at clinical@webuildhearts.org for enrollment information.
Where is the NCT06588426 trial being conducted?
This trial is being conducted at Rochester, United States.
Who is sponsoring the NCT06588426 clinical trial?
NCT06588426 is sponsored by HeartWorks, Inc.. The trial plans to enroll 100 participants.